NCT04704349
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Cardiovascular Diseases, +29 more
- Locations
-
- CHR d'Orleans Orléans, France
Clinical trial condition
Parkinsonian Disorders
Explore clinical trials studying Parkinsonian Disorders. Study availability and eligibility vary by location and protocol.
148 public trials
32 recruiting studies
Parkinsonian Disorders trial results
NCT03156647
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Hôpital Gui de Chauliac Montpellier, France
- Hôpital St Eloi Montpellier, France
- CHU Nimes Nîmes, France
NCT04974034
- Conditions
- Akinesia, Basal Ganglia Diseases, Bradykinesia, +14 more
- Locations
-
- Hospital Avicenne Bobigny, Seine Saint Denis, France
Completed
Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.
NCT01380899
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Hospital Central Dr. Ignacio Morones Prieto San Luis Potosí City, Mexico
NCT03076671
- Conditions
- Alzheimer Disease, Aphasia, Aphasia, Primary Progressive, +52 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- University of Colorado Denver Aurora, Colorado, United States
NCT01272687
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Fachkrankenhaus für neurologische Akut- und Rehabilitationsmedizin Bad Neustadt an der Saale, Germany
- Universitätsklinikum Dresden Klinik für Neurologie Dresden, Germany
- University of Giessen, Department of Neurology Giessen, Germany
- Ernst-Moritz-Arndt-University of Greifswald, Department of Neurology Greifswald, Germany
NCT03386669
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Chang Gung Memorial Hospital,Linkou Taoyuan City, Guishan Dist, Taiwan
NCT01491932
- Conditions
- Anti-Dyskinesia Agents, Basal Ganglia Diseases, Brain Diseases, +11 more
- Locations
-
- Novartis Investigative Site Englewood, Colorado, United States
- Novartis Investigative Site Kansas City, Kansas, United States
- Novartis Investigative Site Milwaukee, Wisconsin, United States
- Novartis Investigative Site Innsbruck, Austria
NCT01491529
- Conditions
- Anti-Dyskinesia Agents, Basal Ganglia Diseases, Brain Diseases, +11 more
- Locations
-
- Novartis Investigative Site Sunnyvale, California, United States
- Novartis Investigative Site Englewood, Colorado, United States
- Novartis Investigative Site Tampa, Florida, United States
- Novartis Investigative Site Kansas City, Kansas, United States
NCT01385592
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
- Locations
-
- Novartis Investigative Site Sunnyvale, California, United States
- Novartis Investigative Site Englewood, Colorado, United States
- Novartis Investigative Site London, Ontario, Canada
- Novartis Investigative Site Gatineau, Quebec, Canada